Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Potential biomarkers for early detection of liver cancer

Potential biomarkers for early detection of liver cancer

New drug therapy zaps hepatitis C in 12 weeks

New drug therapy zaps hepatitis C in 12 weeks

Use of computer-assisted drug design in drug discovery

Use of computer-assisted drug design in drug discovery

Recognition for cancer researchers

Recognition for cancer researchers

Blueprint for cell, tissue and organ donation and transplantation

Blueprint for cell, tissue and organ donation and transplantation

Hepatitis A and Hepatitis B cases at lowest levels ever reported

Hepatitis A and Hepatitis B cases at lowest levels ever reported

Mayo Clinic tests engineered measles virus against multiple myeloma

Mayo Clinic tests engineered measles virus against multiple myeloma

The model for end-stage liver disease

The model for end-stage liver disease

Hepatitis B found in sweat of Olympic athletes

Hepatitis B found in sweat of Olympic athletes

New type of buckyball

New type of buckyball

Nanoparticles from crab shells show promise for drug delivery

Nanoparticles from crab shells show promise for drug delivery

Anabolic steroids and antisocial behaviour go together

Anabolic steroids and antisocial behaviour go together

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

Eating mandarins reduces the risk of liver disease, hardened arteries and insulin resistance

Eating mandarins reduces the risk of liver disease, hardened arteries and insulin resistance

Colchicine delays development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis

Colchicine delays development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis

Fewer deaths from cancer in the U.S.

Fewer deaths from cancer in the U.S.

Turning the immune system against cancer

Turning the immune system against cancer

Cancer Research Technology announce collaboration with Hammersmith Hospital to develop high intensity focused ultrasound for the treatment of cancer

Cancer Research Technology announce collaboration with Hammersmith Hospital to develop high intensity focused ultrasound for the treatment of cancer

Nexavar approved in Europe for treatment of advanced kidney cancer

Nexavar approved in Europe for treatment of advanced kidney cancer

FDA approves fully automated screening tests for hepatitis B surface antigen

FDA approves fully automated screening tests for hepatitis B surface antigen